FDA Approves Therapy for Cerebral Folate Deficiency - Top_Thought_Leaders - MDSpire

Login

FDA Approves Therapy for Cerebral Folate Deficiency

Decision addresses a rare neurologic disorder linked to folate transport impairment.

By
Kathryn Wighton
March 10, 2026
2 min

Conexiant

Share

Top Thought Leaders in Urology

Brief introduction explaining scope and methodology.

Original Source(s)

Conexiant

FDA Approves Therapy for Cerebral Folate Deficiency

by Kathryn Wighton
March 10, 2026

Related Content

The Medicine Maker

This Week’s CGT News: Novo’s Parkinson’s Pivot

Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward

May 18, 2026
7 min

Frontiers In Pediatrics

IQSEC2-related developmental and epileptic encephalopathy with a Rett-like phenotype: two cases with novel variants and a review of the literature

by Li Cheng, Bo Lei, Li Geng, Dan Li, Chaobin Zhou, Chengfang Yan, Qingtao Chen, Maoqiang Tian
May 14, 2026

Jama Network Open

FDA Approves Therapy for Cerebral Folate Deficiency

Top Thought Leaders in Urology

Kathryn Wighton

The ASCO Post Staff

Andrea Surnit

Kerri Miller

Jo Cavallo

Matthew Stenger

Teraya Smith

Conexiant News Staff

Julie Greenbaum

Henry Thomas

Original Source(s)

FDA Approves Therapy for Cerebral Folate Deficiency

Related Content

This Week’s CGT News: Novo’s Parkinson’s Pivot

IQSEC2-related developmental and epileptic encephalopathy with a Rett-like phenotype: two cases with novel variants and a review of the literature

High-Dose Vitamin D 3 Supplementation During Pregnancy and Test-Based Cognitive Performance at Age 10 Years: A